Abstract:Streptomyces is taken as an important resource for producing the most abundant antibiotics and other bio-active natural products, which have been widely used in pharmaceutical and agricultural areas. Usually they are biosynthesized through secondary metabolic pathways encoded by cluster situated genes. And these gene clusters are stringently regulated by interweaved transcriptional regulatory cascades. In the past decades, great advances have been made to elucidate the regulatory mechanisms involved in antibiotic production in Streptomyces . In this review, we summarized the recent advances on the regulatory cascades of antibiotic production in Streptomyces from the following four levels: the signals triggering the biosynthesis, the global regulators, the pathway-specific regulators and the feedback regulation. The production of antibiotic can be largely enhanced by rewiring the regulatory networks, such as overexpression of positive regulators, inactivation of repressors, fine-tuning of the feedback and ribosomal engineering in Streptomyces . The enormous amount of genomic sequencing data implies that the Streptomyces has potential to produce much more antibiotics for the great diversities and wide distributions of biosynthetic gene clusters in Streptomyces genomes. Most of these gene clusters are defined cryptic for unknown or undetectable natural products. In the synthetic biology era, activation of the cryptic gene clusters has been successfully achieved by manipulation of the regulatory genes. Chemical elicitors, rewiring regulatory gene and ribosomal engineering have been employed to crack the potential of cryptic gene clusters. These have been proposed as the most promising strategy to discover new antibiotics. For the complex of regulatory network in Streptomyces , we proposed that the discovery of new antibiotics and the optimization of industrial strains would be greatly promoted by further understanding the regulatory mechanism of antibiotic production.

Progress in strategies for cloning of antibiotics biosynthetic gene clusters

Toward steadfast growth of antibiotic research in China: from natural products to engineered biosynthesis.

Secondary metabolic pathway genes and new drug discovery

Recent Advances in Strategies for the Cloning of Natural Product Biosynthetic Gene Clusters

Genome Engineering and Modification Toward Synthetic Biology for the Production of Antibiotics

The “Three Cs” of Novel Antibiotic Discovery and Production through Synthetic Biology: Biosynthetic Gene Clusters, Heterologous Chassis, and Synthetic Microbial Consortia

Recent advances in awakening silent biosynthetic gene clusters and linking orphan clusters to natural products in microorganisms

Bioprospecting Through Cloning of Whole Natural Product Biosynthetic Gene Clusters

Recent advances in activating silent biosynthetic gene clusters in bacteria

Recent Advances in Silent Gene Cluster Activation in Streptomyces

Recent Advances in Strategies for Activation and Discovery/Characterization of Cryptic Biosynthetic Gene Clusters in Streptomyces

Genome Engineering and Direct Cloning of Antibiotic Gene Clusters Via Phage Φbt1 Integrase-Mediated Site-Specific Recombination in Streptomyces.

Combinatorial biosynthesis of novel aminoglycoside antibiotics via pathway engineering

The Biosynthetic Gene Clusters of Aminocoumarin Antibiotics

Genetic Engineering of Antibiotic Biosynthesis for the Generation of New Aminocoumarins

Progress on Enhancing Antibiotic Yield by Genetic Engineering

Strategy for Efficient Cloning of Biosynthetic Gene Clusters from Fungi.

The Application of Regulatory Cascades in <i>Streptomyces</i>: Yield Enhancement and Metabolite Mining

Recent advances in heterologous expression of natural product biosynthetic gene clusters in Streptomyces hosts

Recent advances in the heterologous expression of microbial natural product biosynthetic pathways

The Application of Regulatory Cascades in Streptomyces: Yield Enhancement and Metabolite Mining